Origin

18 posts

Origin banner
Origin

Origin

@origin_bio

AI for safer cell and gene therapies

San Francisco, California Katılım Eylül 2025
0 Takip Edilen1.3K Takipçiler
Origin retweetledi
Yash Rathod
Yash Rathod@YashRathod_75·
Today, we're excited to release 10,000 fully AI-designed enhancer sequences for the research community. Axis was prompted to design sequences with targeted activity in one of three widely used cell-lines. AI allows us to explore a vast design space, going beyond the natural genome.
English
15
52
300
94.3K
Origin retweetledi
Viraj Doshi
Viraj Doshi@viraj9451·
Muon can accelerate LLM training, but does that benefit transfer to regulatory DNA sequence modeling with its different data distribution? 🧬 Our results show that Muon with independent weight decay (MuonW) hits our validation perplexity target in ~37% fewer FLOPs than the best Adam configuration.
Viraj Doshi tweet mediaViraj Doshi tweet mediaViraj Doshi tweet mediaViraj Doshi tweet media
English
5
22
121
10.6K
Origin retweetledi
Origin retweetledi
malhar
malhar@malhar317·
Cell and gene therapies have the potential to offer a much higher quality of life to patients. Getting transcriptional control right is going to unlock a whole new class of them. Happy to share a small preview into Axis’ ability to design novel regulatory DNA sequences. It’s so obvious that evolution has only explored a drop in the whole ocean. Now finally with AI can we start to take a deep dive.
malhar tweet mediamalhar tweet media
Y Combinator@ycombinator

Origin (@origin_bio) is using AI to make safer cell & gene therapies for diseases like cancer. Their model designs DNA switches & dials to program precise gene expression patterns in disease cells. Congrats on the launch @YashRathod_75 and @malhar317! ycombinator.com/launches/PMG-o…

English
2
5
37
9.7K
Origin retweetledi
Yash Rathod
Yash Rathod@YashRathod_75·
We're still in the early days of durable and long lasting drugs based on transcriptional control - similar to where mRNA medicines were many years ago! With AI designed regulatory DNA and millions of sequences we're lab testing, we aim to precisely program gene expression @origin_bio
Y Combinator@ycombinator

Origin (@origin_bio) is using AI to make safer cell & gene therapies for diseases like cancer. Their model designs DNA switches & dials to program precise gene expression patterns in disease cells. Congrats on the launch @YashRathod_75 and @malhar317! ycombinator.com/launches/PMG-o…

English
1
7
23
2.5K
Origin
Origin@origin_bio·
Interested in knowing more about how we beat Google DeepMind? We shared some insights on @tbpn
English
3
7
60
10.6K
Origin
Origin@origin_bio·
On TBPN live, our co-founder and CEO shares more on how we plan to use Axis to develop new age gene therapies👇
English
1
9
65
8.8K
Origin retweetledi
Yash Rathod
Yash Rathod@YashRathod_75·
Going on TBPN at 1:45 pm PT to launch @origin_bio and our model, Axis. Axis is the first model that generates regulatory DNA sequences and predicts its function. Axis already outperforms DeepMind's AlphaGenome on various benchmarks!
TBPN@tbpn

Morning. On today’s show: – @karimatiyeh (Ramp) – @alexkshieh (The Antifraud Co) – @dteare (1Password) – @gilbert & @djrosent (Acquired) – @sergiynest (Quilter) – @jlopas (Base Power Co) – @ryanjdaniels (Crosby) – @zganieany (MeritFirst) – @yashrathod_75 (Origin) See you there.

English
4
10
51
20.6K
Origin
Origin@origin_bio·
We’re excited to take the model into the lab and open up public access soon! To get early access to the model, please fill out the form here: tinyurl.com/origin-axis-ac… If you enjoyed this thread and want to learn more about Axis, read our blog post: origin.bio/introducing-ax…
English
1
8
44
4.3K
Origin
Origin@origin_bio·
Natural genomes capture only a fraction of possible sequence designs permitted by underlying rules. Models like Axis explore this design space and can generate regulatory sequences that encode circuit-like logic, enabling cell type and state-specific activity.
GIF
English
1
5
44
5K
Origin
Origin@origin_bio·
Introducing Axis: the first AI model that generates regulatory DNA elements and predicts their function. Gene therapies suffer from poor efficacy, toxicity & specificity. Models like Axis can help overcome such risks. Axis beats Google DeepMind's AlphaGenome at predicting regulatory element binding activity by 6.7%.
GIF
English
75
133
540
427.3K